orphan drug designation
Scope
Date
~
-
Bio & Pharma
Celltrion develops oral antibody drug with US bio company
South Korea's biopharmaceutical company Celltrion Inc. on Monday said it signed an R&D contract with US-based Rani Therapeutics on RT-111, an or...
Jan 09, 2023 (Gmt+09:00)
-
Travel & Leisure
MyRealTrip launches overseas lodging booking service
Travel app MyRealTrip said Wednesday that it is launching an overseas hotel booking service that allows users to search, book, and pay for more than...
Jan 06, 2023 (Gmt+09:00)
-
Korean Innovators at CES 2023
LG unveils self-driving auto parts, brighter OLED panels
LG Group’s two units have showcased new automotive and display products, which would expand their presence in the autonomous driving and premi...
Jan 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong, Onchorus to undertake research on mRNA anticancer drugs
Daewoong Pharmaceutical said on Thursday that it has signed a joint R&D and commercialization agreement with America's biopharmaceutical venture...
Jan 05, 2023 (Gmt+09:00)
-
Shipping & Shipbuilding
Samsung Heavy certified for CMSR power barge design
South Korea's main shipbuilder Samsung Heavy Industries said on Wednesday that it has completed the conceptual design for the compact molten salt re...
Jan 04, 2023 (Gmt+09:00)
-
Bio & Pharma
HLB confirms ophthalmic disease treatment in phase 3 clinical trials
South Korea’s biomedicine startup HLB Therapeutics Co. said on Monday that its Neurotrophic Keratopathy (NK) treatment RGN-259 proved effectiv...
Jan 03, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharma, Neurolive to jointly develop new antidepressant drug
South Korea's drug company Daewoong Pharmaceutical said on Wednesday that it has signed an agreement with biopharmaceutical venture Neurorive to joi...
Dec 28, 2022 (Gmt+09:00)
-
Bio & Pharma
KOICA donates Celltrion's Herzuma to Ukraine
Celltrion Healthcare Co. said on Monday that Herzuma (ingredient name: Trastuzumab) was dispatched to patients in Ukraine by the Korea International...
Dec 26, 2022 (Gmt+09:00)
-
Bio & Pharma
CJ applies to FDA for trials of immuno-anticancer drug candidate
CJ Bioscience, an independent red bio (pharmaceutical and healthcare) subsidiary of CJ CheilJedang Corp., said on Monday it has submitted a phase 1 ...
Dec 26, 2022 (Gmt+09:00)
-
Electronics
Samsung, LG to showcase high-end home appliances at CES 2023
South Korea's Samsung Electronics Co. and LG Electronics Inc. are set to showcase their high-end home appliances at the CES 2023, the world's larges...
Dec 26, 2022 (Gmt+09:00)
-
Bio & Pharma
LegoChem Bio, Amgen sign ADC platform deal for up to $1.2 bn
South Korean pharmaceutical firm LegoChem Biosciences Inc. said on Dec. 23 it has transferred the antibody-drug conjugates (ADC) technology platform...
Dec 23, 2022 (Gmt+09:00)
-
Bio & Pharma
Dong-A ST incorporates NeuroBo as subsidiary
Dong-A ST said on Friday that it would acquire American drug company NeuroBo Pharmaceuticals as a subsidiary.NeuroBo, located in Boston, is a Nasdaq...
Dec 23, 2022 (Gmt+09:00)
-
Aerospace & Defense
KAI to develop Korea's first mine-sweeper helicopter
Korea Aerospace Industries Ltd. (KAI) is poised to start R&D on a minesweeper helicopter that specializes in removing underwater mines.The compa...
Dec 23, 2022 (Gmt+09:00)
-
Bio & Pharma
S.Korean biopharmaceutical sector to see brisk M&As in H1, 2023
An expert says the first half of next year will see the start of brisk M&As in biopharmaceuticals targeting strategic investors.Pyeon Jae-seong,...
Dec 21, 2022 (Gmt+09:00)
-
Artificial intelligence
Syntekabio launches new drug development platform STB Cloud in US
Syntekabio,Inc., a South Korean artificial intelligence (AI) drug development company, said on Monday it has launched its cloud-based AI drug develo...
Dec 19, 2022 (Gmt+09:00)
-
Automobiles
S.Korean startup enters UK market for wireless charging of EVs
A South Korean startup will enter the British market for wireless charging facilities for electric vehicles (EV), as Korean firms speed up their adv...
Dec 19, 2022 (Gmt+09:00)
-
Bio & Pharma
LG Chem in $95.5 million drug out-licensing deal with China’s Innovent
LG Chem Life Sciences, the biopharmaceutical unit of LG Chem Ltd., and China’s biotech company Innovent Biologics have entered into a strategi...
Dec 15, 2022 (Gmt+09:00)
-
Bio & Pharma
Daewoong submits new drug applications for Fexuclue in 10 countries
South Korea's leading drug company Daewoong Pharmaceutical is accelerating its global expansion efforts for its 34th domestically developed drug Fex...
Dec 14, 2022 (Gmt+09:00)
-
Bio & Pharma
S. Korea's SillaJen launches clinical trials in US for new anti-cancer drug
South Korean biotech company Sillajen Inc. has started recruiting patients for Phase 1 clinical trials in the US for an anti-cancer drug from a Swis...
Dec 14, 2022 (Gmt+09:00)
-
Bio & Pharma
LG Chem confirms diabetes drug Zemidapa's efficacy in phase 3 trials
LG Chem Ltd. announced in a disclosure on Monday that it had confirmed superior efficacy in phase 3 clinical trials for the combined administration ...
Dec 13, 2022 (Gmt+09:00)
-
Bio & Pharma
New drug developer Onconic Therapeutics raises $20 mn in Series B
South Korean drug developer Onconic Therapeutics, announced on Friday that it raised 26 billion won ($19.9 million) in Series B funding, with cumula...
Dec 09, 2022 (Gmt+09:00)
-
Bio & Pharma
SK Biopharmaceuticals launches epilepsy drug in France
South Korean SK Biopharmaceuticals Co. said on Friday that its treatment of epilepsy "Cenobamate" has been approved for sale in France.The company l...
Dec 09, 2022 (Gmt+09:00)
-
Artificial intelligence
Samsung, Naver agree to partner in developing next-gen AI semiconductor solutions
Samsung Electronics Co. and Naver Corp. have agreed to cooperate in developing next-generation AI semiconductor solutions optimized for artificial i...
Dec 06, 2022 (Gmt+09:00)
-
Tech, Media & Telecom
SK Telecom wins global awards for innovative virtualization technology
SK Telecom, a leading South Korean 5G services provider, announced on Sunday that it won two global awards: Global Telecom Awards 2022 and Leading L...
Dec 05, 2022 (Gmt+09:00)
-
Bio & Pharma
Korea approves Daewoong Pharmaceutical's diabetes drug
DAEWOONG PHARMACEUTICAL has received domestic approval for its diabetes drug Envlo with the active ingredient enavogliflozin, the second straight ye...
Dec 02, 2022 (Gmt+09:00)
-
Automobiles
Nexen Tire and Design Council Busan join hands for futuristic models
Nexen Tire said on Thursday that it has developed three types of future concept tires, including "BTR," "Mearth," and "Nocturne," in collaboration...
Dec 01, 2022 (Gmt+09:00)
-
Bio & Pharma
Spectrum to push back launch date of Hanmi-developed drug Poziotinib
Hanmi Pharmaceutical Co. announced Friday that California-based Spectrum Pharmaceuticals Inc. received a Complete Response Letter (CRL) from the US ...
Nov 25, 2022 (Gmt+09:00)
-
Automobiles
Hyundai to resurrect 1974 Pony Coupe concept with designer Giugiaro
Back in 1974, Hyundai Motor Co. was nobody in the auto industry.With no decent vehicle design and styling capabilities, the South Korea carmaker app...
Nov 24, 2022 (Gmt+09:00)
-
Bio & Pharma
Mezzion Pharma to try again for US FDA approval of drug
South Korea's Mezzion Pharma will seek to get the oral medicine Udenafil to treat side effects from heart surgery, planning to clinical trials in th...
Nov 23, 2022 (Gmt+09:00)
-
Electronics
Samsung, LG products sweep CES 2023 innovation awards
South Korea’s two largest home appliance makers – Samsung Electronics Co. and LG Electronics Inc. – have swept a record number of ...
Nov 17, 2022 (Gmt+09:00)
Latest News
- 1 Coupang bids for Korean luxury market dominance with Farfetch
- 2 Hyundai Rotem set to finalize $6 bn K2 tank order from Poland
- 3 Lee Jae-myung to meet with top business leaders this week ahead of G7 summit
- 4 Korea to allow non-profits to buy bad consumer loans
- 5 LG to drive future growth in emerging markets with battery prowess